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Abstract: Materials that confer antimicrobial activity, be that by innate property, leaching of biocides
or design features (e.g., non-adhesive materials) continue to gain popularity to combat the increasing
and varied threats from microorganisms, e.g., replacing inert surfaces in hospitals with copper.
To understand how efficacious these materials are at controlling microorganisms, data is usually
collected via a standardised test method. However, standardised test methods vary, and often the
characteristics and methodological choices can make it difficult to infer that any perceived antimicro-
bial activity demonstrated in the laboratory can be confidently assumed to an end-use setting. This
review provides a critical analysis of standardised methodology used in academia and industry, and
demonstrates how many key methodological choices (e.g., temperature, humidity/moisture, airflow,
surface topography) may impact efficacy assessment, highlighting the need to carefully consider
intended antimicrobial end-use of any product.
Keywords: antimicrobial materials; antimicrobial testing; 22196; antimicrobial surfaces; antibacte-
rial coatings
1. Introduction
In order for a microorganism to cause disease, it must first reach the potential host.
Microorganisms can move around an environment in various but typically passive ways,
including via aerosols (inside droplets of water) [1], direct contact between two animated
objects [2], and fomites (a contaminated inanimate object) [3]. Some microorganisms can
retain their pathogenic potential whilst outside their host for extended periods of time [4],
with studies suggesting survival for days and even weeks on inanimate surfaces such
as plastics and metals which are often considered to be ‘hygienic surfaces’ [5,6]. Many
of these materials are used to construct frequently touched surfaces (FTS) such as door
handles, lift buttons, light switches and digital locks [7,8]. Viability of microorganisms
on FTS has been demonstrated, and more critically, the evidence of transfer of potentially
harmful microorganisms from the FTS to a biological surface (e.g., human skin) via touch
has also been reported numerous times in the literature, e.g., [9–11]. In the clinical setting,
studies highlight bedsteads, supply carts, over-bed tables, lockers, patient bodies, bed-
linen, curtains and intravenous pumps as frequently touched when specifically considering
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interactions between hospital staff and patients [12,13]. These patient-care items can serve
as a potential reservoir for pathogenic microorganisms and may be the cause of infection
of, and cross-infection between, hospital patients. Non-clinical environmental reservoirs of
pathogens can cause further problems where compounding factors also occur, such as on
cruise ships where advanced medical treatments are not available [14].
There are various methods that can be utilised to control microorganisms on surfaces in
these settings. In clinical environments, methods to chemically disinfect surfaces are often
used, but may be performed inadequately, (through poor adherence to cleaning protocols),
allowing pathogens to be spread more rapidly throughout wards, following recontami-
nation of disinfected surfaces via contact with fomites [15]. Additionally, disinfectants
may themselves drive the evolution of resistance. For example, quaternary ammonium
compounds (QAC) have long been considered an effective class of disinfectants and were
once thought to be impervious to bacterial resistance. However, an approximate 30%
increase of QAC resistance genes has been observed in methicillin-resistant Staphylococcus
aureus (MRSA) isolates in the years 1990–2010 [16]. To compound this issue further, QAC
resistance can undergo horizontal gene transfer to spread resistance and can also propagate
the transfer of other antibiotic resistance genes [17]. Disinfecting rooms through exposure
to high intensity UV light can be effective at killing the majority of microorganisms it
illuminates, but requires all staff and patients to leave the room during the process as a
safety requirement [18].
Therefore, methods that reduce human error and do not impact on the availability of
facilities would be beneficial, such as materials that exhibit antimicrobial activity. Such
materials may be innately antimicrobial, produced with a biocide embedded within, or
there may be some coating or treatment that confers antimicrobial properties onto the
surface—many of which have gained popularity over recent years [19]. For example,
in some hospitals and other end-use environments, copper has been exploited as an
antimicrobial material (AMM) [20], whilst brass has also been used extensively for FTS,
demonstrating an oligodynamic effect [21]. Other materials and additives are now gaining
focus in the literature, for example, materials with photocatalytic properties such as certain
forms of titanium dioxide, various metal salts and oxides as well as certain dyes [22], other
metal ions [23] and some organic agents [24] and materials used in their nano form, such
as silver, copper and zinc [25]. Due to the variety and scope of these materials, we will use
the term AMM to describe such materials.
The mechanism of action of AMMs can be divided into three major subgroups: active
substance release, potentiated surfaces and non-adhesive properties. Each of these ap-
proaches has their own advantages and limitations in situ [26]. Contact killing-based claims
are the most abundant in the literature, being delivered by both active substance release
systems and those with potentiated surfaces. Arguably systems that release less active
substance may mitigate any increase in prevalence of antimicrobial resistance associated
with AMM’s [27].
Active substance release systems discharge a biocide or antimicrobial agent and this is
often triggered through hydration which is then intended to kill microorganisms on the
surface and can be highly effective [28]. They can be applied to and incorporated into a
wide range of materials (e.g., synthetic polymers) and deployed in a wide range of environ-
ments, from FTS in hospital wards to internal devices in patients such as orthopaedic and
cardiovascular implants [29], as well as in non-clinical environments such as call buttons
and in coatings on hand rails on public transport [30].
Potentiated surface-based AMM’s can be fabricated by the inclusion of a biocide,
metal, peptides or amines on the surface of the material in order to add an antimicrobial
function to that surface [31–33]. Common materials used include silver nanoparticles
(AgNPs) [25,34,35], copper (Cu) [36–39], tin disulphide (SnS2) [40], ruthenium (Ru) [41,42]
and titanium dioxide (TiO2) [43]. Within this subcategory of AMMs are photocatalytic
materials, that present their antimicrobial effect when exposed to light (e.g., TiO2); however,
a longer time period is often required to significantly reduce the microbial bioburden, with
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hours upon exposure to typical solar light [44]. However, doping (e.g., nitrogen [45]) does
add further potential for increased efficacy [46].
In addition to the mechanisms described above, which focus on a molecule entering
or interacting with a cell in some detrimental way, other mechanisms for modifying and
potentiating surfaces also exist. For example, carbon nanomaterials (e.g., graphene oxide)
have also been shown to be effective at reducing the microbial bioburden on a surface by
piercing/damaging cells using jagged, sharp and sturdy surface features [47]. Graphene
oxide can also ‘generate’ reactive oxygen species (ROS) [48], and therefore uses multiple
features to achieve the desired antimicrobial effect [49].
Non-adhesive AMMs have been designed to combat the transfer of microorganisms,
as they prevent a microorganism from being able to adhere to the surface, which is therefore
also easily cleaned (e.g., by presenting hydrophilic properties [50]). However, it is important
to note that an AMM only incorporating this method would likely not reduce the rate of
infection in patients, as studies have shown that, particularly bacteria, are able to overcome
this ‘line of defence’ when no other antimicrobial properties are being exhibited [51].
As described above, there exists a range of applications for which an antimicrobial
surface may be a desired option in some settings, with numerous options for manufac-
turers including different materials/additives and manufacturing processes. However,
the variation in approach means that not all AMMs are equal and are likely to all exhibit
individual levels of efficacy specific to their product design and intended end-use. As the
market for these materials increases, manufacturers of AMMs are required to demonstrate
their materials work as intended—meaning efficacy testing is a critical component in AMM
development, sale, purchase and end-use decision-making.
2. Testing the Efficacy of an AMM
Standardised test methods are a necessary and important step in the development
of a novel antimicrobial material. To define a material as antimicrobial, efficacy should
be assessed under reproducible conditions that mimic later in-use environments. If the
predetermined threshold (usually a 2 or 3-log reduction in viable cells although often
individually agreed upon by all parties involved) is not met, then the surface cannot be
considered as antimicrobial. This process should enable those interested in AMM’s to
ascertain a level of confidence in their material, providing some preliminary positive data
that encourages further exploration for testing the material either under conditions more
appropriate to the intended point of use or even in practice. For example, bacterial inocula
used in standardized testing (~105–108 CFU/mL) are significantly higher than those found
in most potential end-use settings (e.g., ~102–104) [52].
Additionally, in order to validate the reproducibility of an antimicrobial material,
ideally several different labs should perform the relevant standardised test method and
achieve results that are all within the natural error range for such test [53]. Whilst the
validity of individual test method data should be acknowledged, a growing need exists for
precise and reproducible methods, as many different AMM´s fall short when being tested
by independent reviewers [54].
In several cases, the test methods used to determine the efficacy of an AMM are
inadequate due to a variety of factors including the incubation time/environmental condi-
tions. In some cases this can artificially favour the increased and/or prolonged efficacy
of the material, particularly by raising the humidity to >90%, a condition which is almost
never seen in end-use environments [55,56]. Many of the materials used in AMM’s require
moisture to be antimicrobial, metallic silver for example, which is ionised in the presence
of moisture to form silver ions which have numerous antimicrobial properties. Therefore,
knowledge of the length of time a surface remains moist for (the drying time of the deposit
carrying the contaminating microorganism on the surface) is vital for an accurate judge-
ment on the efficacy of the surface [57]. This reliance on moisture must be considered when
testing surfaces for effectiveness at point of use. Indeed, knowing the time it takes for an
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inoculum (a suspension of microbial cells of any manner) applied as a liquid to dry in each
environment is key to assessing the activity of many AMMs.
3. Standardised Tests for AMMs In Vitro
There are five general categories of test for an antimicrobial material in vitro: (1) high
surface area to volume ratio tests, (2) agar zone of inhibition tests, (3) suspension tests,
(4) adhesion tests, (5) biofilm tests [26]. These tests differ based on the mechanism of
action they are intended to evaluate (among other factors) and are explored below. Many
test methods are constructed and defined by several different test method development
organisations such as ISO (International Standards Organisation), BS (British Standards),
IBRG (International Biodeterioration Research Group), and ASTM (American Society
for Testing and Materials). There have been many iterations and modifications of these
methods described in the literature that deviate based on the individual preferences of the
testing laboratory, which then makes comparison of data generated for similar materials in
different laboratories problematic.
3.1. Methods Constituting High Surface Area to Volume Ratio
These methods focus on maximising the contact between the surface and the mi-
croorganism, so the cells and the surface are essentially always touching and interacting.
This is usually done by placing the bacteria between the test sample and another ster-
ilised non-antimicrobial material such as glass or plastic. The most used test method for
antimicrobial materials in this category is ISO 22196:2011 (and similar methods such as
JIS Z 2801). Here, a surface is inoculated with a bacterial suspension of known concentra-
tion and volume (Figure 1). A polyethylene film is placed on top of the inoculum, and the
material is incubated at 35 ◦C in upwards of 90% humidity for 24 h. Bacteria are removed
from the surface by mechanical detachment and re-suspension in a neutralising diluent,
before the number of colony forming units (CFUs) is determined by plate count [58]. This
method is relatively straight-forward and cheap to run, and so has been widely adopted.
However, none of the experimental conditions relate to end-use environments. Indeed, in
the majority of cases, the opposite is true, ISO 22196:2011 keeps a microbial inoculum wet
for the duration of a 24-h test, allowing the antimicrobial material to provide a sustained
antimicrobial action by dissolving into the water and this way ensuring contact between
the cell wall of a microorganism and the biocidal active substance—which will not mirror
the conditions when an AMM is implemented. To overcome such shortcomings, recent
developments include a test method where bacteria are aerosolised, so they are deposited
onto a dry surface, in an attempt to reduce artificial antimicrobial action resulting from the
deposition of a wet microbial inoculum [59]. However, dry deposition is not without its
own challenges, for example ensuring reproducible inoculum quantity and ensuring a safe
working environment from the release pathogens into the air.
Other methods using a high surface area to volume ratio have been reported in the
literature. One method (a modification of ISO 22196:2011) involves inoculation of the
antimicrobial material with a bacterial suspension within a film of agar (commonly made
into a slurry) to ensure that contact is maintained between the AMM and the test organism.
When recovering the bacteria from the material, a neutraliser is used to resuspend the
inoculum (neutralising diluent is a key step in a majority of antimicrobial test methods
to prevent superfluous interactions between the material and microorganism) and CFU
counts are determined. However, it is possible that the slurry (when required) has a soiling
effect on the material preventing it from performing its antimicrobial effect as efficiently as
possible as different antimicrobial materials will present largely different diffusion rates
and characteristics into an agar slurry [60,61].
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Figure 1. Diagram describing important steps in the ISO 22196 antimicrobial materials efficacy test.
Another modification of ISO 22196:2011 uses a filter, inoculated with bacteria, as the
top layer rather than a polyethylene film perhaps to reduce loss of microorganisms through
fewer manipulations (omitting drop inoculation) [62]. Alternatively, a liquid bacterial
suspension can be sprayed (to simulate the typical deposition of airborne bacteria on to
a surface by coughing, etc.) on to the antimicrobial material from a distance of 15 cm,
followed by live-dead staining after being air-dried for two minutes. Spraying of microbes
rather than deposition has the advantage of being more representative of a patient in a
hospital in most cases but is more complicated to run (and standardise) than simply placing
a droplet of water on to the surface, as it requires specialist equipment.
In conclusion, several authors have developed methods that are related to ISO 22196,
presumably due to their ease of use and relatively low cost. However, there are many
limitations in the translation of results obtained to the point of use of the materials, with
most relating to the dissimilarity of the conditions standardised in ISO 22196 compared to
end-use environments, both clinical and non-clinical, and others arising from difficulties in
comparing results from methods that slightly differ from laboratory to laboratory.
3.2. Agar Zone of Inhibition Methods
Methods that utilise zones of inhibition, for which there are two existing standardised
methods, are relatively quick and simple but may provide only an indicator of whether
any antimicrobial effect might be present under permanently wet conditions. The first,
ISO 20645:2004 is based on a disk diffusion method, where the AMM is placed on top of
an inoculated nutrient agar plate, incubated at the required temperature for a set time
depending on the requirements for the bacteria being tested (such as at 37 ◦C for 24 h for
E. coli) [63]. The second, AATCC 30 (which evaluates fungi rather than bacteria), places a
spore suspension on to a solid agar medium and covers that with the AMM, inoculation
with spores also occurs on top of the AMM after placement, the Petri dish is then sealed to
maintain humidity and efficacy evaluation is based on macroscopic or microscopic visibility
of fungi [64]. These methods have limitations such as (i) the incubation temperature is not
relevant to the end use (often it is the optimal growth temperature for the test organism),
(ii) incubation time is not reflective of expected cleaning protocols (FTS’s are likely to be
touched more than once per day), and (iii) the nutrients present from the agar would likely
not be present so abundantly on surfaces, all of which reduce the similarity to end-use
environments. In addition, if the active substance is not emitted from the AMM, activity
is unlikely to be measured, limiting applicability to a subset of AMMs. Furthermore, the
viability of the test microorganisms may be compromised by the material being placed
directly on top, even when exhibiting no antimicrobial effect. Nonetheless, the results
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provided from these test methods can allow a quick and simple approach to determining
whether a material has at least some antimicrobial activity, which may be all that is required
at the first stages of product development. Additionally, these methods can be used as a
reliable quality control step during the production of an AMM once approved [65].
3.3. Suspension Methods
Suspension methods focus on inoculating and incubating bacteria in a liquid medium
containing the antimicrobial surface, and then determining the remaining viable CFUs
by taking an aliquot of this liquid and performing a dilution plate count using it. This
allows assessment of materials that exhibit antimicrobial-release properties. However,
due to the inoculum not being placed directly on the material, only surfaces that release
antimicrobials can be tested. There are two current standardised methods. The first, ASTM
E2149-13a, requires that the material is immersed in the medium (that is most appropriate
for the bacteria used) following bacterial inoculation, then after incubation while shaking
to enable increased contact of AMM to the bacteria, the CFU count is determined [66]. This
method was developed with the intention of determining the effectiveness of silane QACs
by agitating the suspension with sufficient vigour to cause cells to come in to contact with
the QAC ‘tails’ [67], although this method is somewhat disputed. A modification to this
method has also been developed whereby the entire suspension container is treated with
the antimicrobial to prevent biofilms forming and to avoid complications arising from the
extensive agitation that is required for the standard [67]. The second, JIS L 1902 (and also
the absorption method within ISO 20743), describes the incubation of a porous material
absorbing a specified volume of the appropriate medium, bacteria are then detached
from the porous material using a stomacher in 20 mL neutralising diluent, and CFUs are
determined in the resultant suspension [68]. For methods where an antimicrobial active
substance has likely leached into liquid media (which will then be diluted and plated
onto agar), which both of these suspension methods utilise, a neutralising solution is
essential—to ensure continued antimicrobial action does not occur during the dilution
and CFU determining incubation stages (24 h at the most appropriate temperature for the
bacterial strain used). As these methods do not assess contact-killing materials, it is not
possible to assess efficacy for using such material in some end-use conditions, for example,
as a touch surface.
3.4. Adhesion Methods
These tests focus on quantifying the number of bacteria that can adhere to an antimi-
crobial material. There are two approaches to this form of testing. The first requires that
the test surface is inoculated with the bacteria and incubated for 1 to 4 h. Non-adhering
bacteria are removed and either the surface with attached cells is added to a liquid medium
or an agar slab is placed on top of the surface and incubated (for counting CFUs), or
the microorganisms can be stained (e.g., live-dead staining) to determine cells per unit
area [69]. The second method specifies a flow of bacterial suspension through a chamber
containing the antimicrobial material, then live-dead staining is performed on the cells
attached to the surface to determine survival status of adhered cells. Alternatively, the
cells are detached from the surface of the material and re-suspended so that the number of
CFUs of the resultant suspension can be calculated [70]. Finally, a proliferation assay can
be used, which involves inoculating an AMM for a given time, followed by rinsing and
placing in a soy medium. The efficacy of the AMM is determined by the number of clonal
counterparts produced by the surviving bacteria that are attached to the AMM, real-time
spectrophotometer readings are essential to creating a growth curve to compare a control
to the AMM [71]. In both methods, there are issues that arise from how effectively the
detachment of bacteria occurs, even by sonication (which can cause the diluent to heat up),
as this may also reduce the viability of the organisms and their growth on media.
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3.5. Biofilm Methods
A biofilm is an assemblage of microorganisms that are associated with a surface and
often become encased in a matrix of polysaccharide material [72–74]. They are one of the
most common forms that microorganisms take on Earth and can cause significant problems
when they form in certain artificial environments. Due to their impact on health, industry
and the environment, the ability to either destroy a biofilm or to stop it from forming
in the first instance using AMMs is a focus of increasing importance. However, biofilm
development and testing are complex, and whilst recent efforts to advance standardised
biofilm growth (e.g., ASTM E2647—20 and ASTM E3161—18) and efficacy testing of
disinfectants against biofilm exist [75,76], methods for efficacy testing of anti-biofilm
materials are limited and suffer from problems regarding quantification of the bacteria, as
staining will offer little insight and sonication may cause a reduction in viability, although
some use of bioreactors for biofilm testing is taking place e.g. [77].
4. Incubation/Environmental Factors Affecting the Efficacy of Antimicrobial
Test Methods
If a test method should inform on the efficacy of a surface under end-use conditions,
the environmental conditions of that test need to be considered carefully. For example, if
moisture is essential for activity of an antimicrobial material, a test method that includes
a high humidity, no airflow and warm temperature will result in the bacterial inoculum
remaining wet for the duration of the test and will provide optimal results for that AMM.
However, if that putative AMM would be used in a more realistic setting (such as a hospital
ward), humidity is likely to be considerably lower (30% to 65%) as will the temperature
(18 ◦C to 28 ◦C), and there will be air circulating (e.g., via movement of doors, people and air
conditioning) [78]. Contaminating droplets of liquid are likely to dry quickly, reducing the
time for which the AMM is active. Most existing standard methods for antimicrobial testing
vary in their environmental condition stipulations, but only to a relatively small degree (as
seen in Table 1). Environmental conditions such as these can alter the efficacy of an AMM,
and therefore careful consideration should be given when designing or interpreting data
from an antimicrobial test method.
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Humidity- Humidity is an important determinant for the drying time of liquid
droplets [79], and therefore is most likely linked to AMM efficacy. In most cases, a reduc-
tion in the humidity of the AMM results in a lower antimicrobial efficacy because of the
reduction in moisture at the surface through evaporation. For example, when assessing the
activity of a copper alloy surface (with varying copper quantities in the alloy), incubating at
37 ◦C and 100% relative humidity (RH) provides a 4-log reduction in around 30 min for all
alloys higher than 70% copper content. However, when the environmental conditions are
more analogous to that of an indoor room, at approximately 20 ◦C and 40–50% RH, the time
taken to achieve the same 4-log reduction of viable bacterial load is doubled to 60 min [80].
In addition, silver ions released from zeolite have demonstrated significant antimicrobial
effect at >90% RH, but the same composition showed no significant antimicrobial effects
at 24% RH and a temperature of 20 ◦C. Although neither RH used in this study can be
considered typical, it highlights the importance of the role that humidity plays in either
increasing or reducing the antimicrobial efficacy of an AMM [55]. Noyce, Michels and
Keevil [56] suggests that silver ions exhibit significantly decreased antimicrobial efficacy
when the humidity is reduced to around 20%, again emphasizing the requirement for
humidity to be considered when performing antimicrobial test methods. Furthermore,
Ronan et al. [81] have shown that desiccation resistance is also significantly affected by the
relative humidity, and this has downstream effects on the microbial survival on a surface,
whereby survival of microorganisms can be greater at lower (25±%) relative humidity’s
compared to higher (95±%), this work also highlights that interactions between bacterial
species also allow for greater survival on materials compared to pure cultures. Finally, this
work uses aerosolisation to deposit bacteria on to the surfaces, alleviating the disadvantages
that droplets at high humidity possess on the antimicrobial efficacy of a material.
Temperature- Temperature has been shown to affect the survival of microorganisms
on a surface, e.g., [82], and has also been shown to significantly affect the release of
antimicrobials from a material [83] and probably the method (or at least the speed) with
which they interact with the target species. Additionally, temperature does significantly
affect the drying time of water on non-porous surfaces [79]—and therefore potentially
affects antimicrobial efficacy due to the resulting change in humidity that occurs.
Airflow- There is limited research into the effect of airflow on drying time and/or
antimicrobial efficacy of a material. However, drying time of a liquid droplet on a non-
porous material has been shown to be slower in the absence of airflow [79]. In addition, the
transfer of infectious aerosols in hospitals is well understood and the ventilation system
has been associated with much of this concern [84]. Thus, airflow is perhaps an important
environmental factor that has been significantly overlooked in the design of testing AMM—
even more so than humidity and temperature as it has never been considered in a relevant
standardised test method.
Surface topography- In addition to the environmental conditions described above,
the surface features such as hydrophobicity and surface roughness can have a significant
impact on how long moisture stays on its surface [85]. While a hydrophilic surface allows
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water to spread out evenly over the whole surface and to dry evenly, a hydrophobic
surface results in the formation of droplets that cover the surface only in parts and that
will dry out slower compared to the same volume when place on a hydrophilic material.
Hydrophobicity and surface roughness will dictate the contact angle created with a droplet;
when the contact angle is larger from an increased hydrophobicity, the droplet will possess
a lower surface area to volume ratio, also therefore decreasing drying time [86].
Spreading of the inoculum- Spreading plays an important part of some antimicro-
bial tests. However, increased care should be taken when considering the spreading of
the inoculum, as inconsistencies in the spreading process are almost inevitable between
laboratories and even individual persons, leading to differences in the drying time of the
droplets/inoculums and the repeatability of the results. Spreading must also be considered
alongside hydrophobicity data of the AMM, as hydrophobicity will partially dictate how
easily, if at all, the inoculum spreads across the surface, further increasing the possibility of
unreliable results [87]. If hydrophobicity/hydrophilicity is part of the function of the coat-
ing comparing results from materials on which the inoculum exhibits dissimilar spreading
rates may be problematic and will need to be taken into consideration.
Inoculum density- Little work has been done linking the addition of an inoculum
to the drying time of a droplet. However, it is likely to cause a difference to drying time
either by interaction of the bacteria with the inoculum (to perform metabolic processes) and
surface, or simply by taking up a certain volume of the inoculum. The impact of soiling
agents in the inoculum may have effects not only on the drying rate, but also by having an
impact on the susceptibility of the target species to the effects of desiccation.
Exposure time- A longer exposure time will allow more interactions between the
microorganism and the surface, potentially causing an increase in antimicrobial effect
(or, under extended conditions its recovery). All current test methods take this factor
into account and specify an exact incubation period for the antimicrobial test to occur—
however, relating this period of time to the end-use is essential, particularly where an
AMM is anticipated to be touched with high frequency.
Threshold to achieve antimicrobial claim- Often a 2–3 log reduction in microbial
viability is required although it is at the discretion of all involved parties to agree to a value
that is considered to be appropriate to the end-use. The scale and speed of an effect must
be appropriate to the benefit that is intended/required.
In addition to those described above, other influences that can have an effect on
efficacy in real-life situations and are often not considered. For example, when testing
include the use of cleaning agents on the AMM, the cleanliness of a surface over time and
the aging of the AMM, especially when using structured surfaces, where topography can
change over time.
5. Discussion
As described above, a variety of test methods exist that are capable of determining
the antimicrobial activity of a material. With this comes variations and alterations to each
method based on the specific conditions of the testing laboratory at the time and date
of testing, among other factors, that will likely affect the accuracy and reliability of the
resulting antimicrobial efficacy of the material. It is worth noting that some modifications
may allow the method to be more appropriate to the question being asked. Whilst the
methodological variation from a standard method is with good intention, for example,
using a temperature the investigator considers closer to room temperature, the effect on
reproducibility can be profound. For example, if two different labs were to consider the
antimicrobial efficacy of a given material, following a standardised test method, but one
used a test chamber/container that was bigger than the other lab, there would be an impact
on the time it takes to reach the intended RH. This would affect the ability of the inoculum
to remain wet on the surface, and therefore alter the time the antimicrobial material is likely
to be active. The same can be true for other experimental factors such as the method of
achieving the desired RH (using concentrations of saturated salts), controlling temperature
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(placing a chamber in an incubator compared to using a heat mat), the speed at which
samples are removed from a chamber for different time points and so on. Often, these
seemingly small changes to methodology alter the reproducibility between laboratories.
For example, one study asked different labs to assess the antimicrobial efficacy of the
same materials (polyamide 6 and an antibacterial zinc additive at multiple concentrations)
using ISO 22196:2011. Following analysis of the data, several factors were found to be
inconsistent between labs, such as extraction medium and method of cell enumeration,
which led to a large disparity in the final results obtained, where the microbial reduction
ranged from 1.73-log to 6.3-log for the same antimicrobial compound [88]. Care should
also be taken to ensure the method of cell enumeration is not only consistent across all
laboratories using a test method but also that it is appropriate for the specific test method
that is being used, live-dead staining for instance is not always effective, particularly when
assessing biofilms [89].
Whilst many of the test methods have been designed to be useable and achievable
in a range of laboratories, issues remain in terms of the validity of the methods. Most
critically, how can efficacy in realistic uses be inferred using the data that the test methods
generate—because the current methods are not reflective of realistic in-use conditions.
It is abundantly clear that a considerable improvement is required in test methodology
of antimicrobial materials if subsequent results are used to support efficacy claims for
different environmental conditions while in use. This clash of intention and inference
would be best addressed by an interdisciplinary approach to new antimicrobial efficacy
test method development. However, the process of making any changes to current test
methods should be taken with due diligence, as unexpected consequences are possible.
For example, temperature and drying time of a droplet have been found to affect the rate
of detachment of Bacillus spores from a surface once the droplet has dried, which will be
more likely to occur if humidity is lowered to 40–50% to keep in-line with a majority of
indoor acclimatised settings [90].
Finally, there have been improvements in recent years that show promise in creating
more realistic and higher reliability test methods. One potentially useful addition would
be the addition of video protocols to work alongside traditional paper protocols, allowing
users to get an exact understanding of the nuances related to the test method. Another
answer may lie in the recent advances in both computer simulations of heat/mass transfer
and in the decreasing cost of improved microfluidic devices that provide the potential for
both cheap and reliable test methods [91], which when integrated in to an environmental
control chamber could provide realistic and reliable antimicrobial efficacy assessment.
6. Conclusions
The utilisation and effectiveness of antimicrobial materials in an end-use scenario
is likely considerably different from results achieved from the testing methods currently
in use and standardised. Using test methods that better reflect end-user environments
would enable more realistic efficacy assessment. An approach to efficacy assessment of
antimicrobial materials should build on current standard methods but seek to understand
and design methods that model the behaviour of the antimicrobial material as if it were
placed in its intended end-use setting, such as by adding additional environmental con-
ditions. However, the increased difficulty and cost, and lack of models that explain the
impact of drying time of liquids deposited on a surface will require significant work to
fully understand and develop into new AMM efficacy test methods.
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